Objectives: Progression of malignant neoplasias is accompanied by alteratio
n of the extracellular matrix (ECM) composition. Tenascin is known as a mem
ber of the adhesion-modulating family of ECM macromolecules; thus its expre
ssion and distribution may have significant influence on tumor cell prolife
ration and invasiveness, Study Design: The present study tvas carried out t
o determine the distribution pattern of tenascin in laryngeal and hypophary
ngeal cancer samples. Methods: In double and triple immunofluorescent stain
ing reactions the detection of tenascin was combined with labelings for cyt
okeratin (marker protein of epithelial cells), for CD-34 (endothelial cell
surface glycoprotein), and for a reaction with Ki-67 monoclonal antibody (n
uclear antigen in proliferating cells). Results: In laryngeal cancers, in e
arly stages of tumor growth a markedly enhanced production of tenascin at t
he tumor host interphase tvas observed, In the later stages of tumor progre
ssion, a high number of blood vessels located in the tumorous tissues were
also strongly labeled for tenascin, Around these vessels a significant numb
er of proliferating tumor cells could be detected, In contrast, in hypophar
yngeal cancers this vasculature-associated staining pattern could be observ
ed from the very early stage of tumor development. In laryngeal and in hypo
pharyngeal cancers, tenascin upregulation strongly correlated with metastas
is formation, early tumor recurrence, and lethal outcome of the disease, Co
nclusions: Clinical and immunohistologic data indicate that the accumulatio
n of tenascin in the tumor blood vessels is an unfavorable prognostic indic
ator in laryngeal and hypopharyngeal cancers.